Cargando…
Mangiferin relieves CCl4-induced liver fibrosis in mice
Hepatic fibrosis is a late stage process of many chronic liver diseases. Blocking the fibrosis process will be beneficial to the treatment and recovery of the diseases. Mangiferin has many pharmacological activities. Recently, it has been reported that mangiferin may relieve tissue fibrosis, includi...
Autores principales: | Zhang, Lijun, Liu, Chuhe, Yin, Liufang, Huang, Cheng, Fan, Shengjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011547/ https://www.ncbi.nlm.nih.gov/pubmed/36914687 http://dx.doi.org/10.1038/s41598-023-30582-3 |
Ejemplares similares
-
Notoginsenoside Fe suppresses diet induced obesity and activates paraventricular hypothalamic neurons
por: Li, Hongli, et al.
Publicado: (2019) -
Hepatocellular Brg1 promotes CCl4-induced liver inflammation, ECM accumulation and fibrosis in mice
por: Wang, Baocai, et al.
Publicado: (2023) -
Adiponectin Agonist ADP355 Attenuates CCl(4)-Induced Liver Fibrosis in Mice
por: Kumar, Pradeep, et al.
Publicado: (2014) -
FOXA2 alleviates CCl(4)-induced liver fibrosis by protecting hepatocytes in mice
por: Wang, Wei, et al.
Publicado: (2017) -
Modulation of duodenal and jejunal microbiota by rifaximin in mice with CCl(4)-induced liver fibrosis
por: Ikeuchi, Kazuhiko, et al.
Publicado: (2023)